Global Laparoscopic Devices Market, by Product Type (Direct Energy System Devices, Trocars/Access Devices, Internal Closure Devices, Laparoscopes, Hand Access Instruments, Insufflation Devices, Robotic Assisted Surgical System), by Therapeutic Application (Bariatric Surgery, Colorectal Surgery, General Surgery, Gynecological Surgery, Urological Surgery, Others (Hematology, etc.)), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 11,974.3 Million in 2022 and is expected to exhibit a CAGR of 6.1% during the forecast period (2022-2030), as highlighted in a new report published by Coherent Market Insights.
Increasing adoption of inorganic strategies such as product approval by regulatory authorities such as Roszdravnadzor, is expected to drive the global laparoscopic market over the forecast period. For instance, in December 2020, TransEnterix, Inc., a medical device company, announced that they had received an approval for the Senhance Surgical System by Roszdravnadzor, the Russian medical device regulatory agency. The Senhance Surgical System is the only digital laparoscopic platform which is designed to maintain laparoscopic minimally invasive surgery standards while providing digital benefits such as robotic precision, comfortable ergonomics, advanced instrumentation including 3 mm micro-laparoscopic instruments eye-sensing camera control, and reusable standard instruments to maintain per-procedure costs similar to traditional laparoscopy.
Global Laparoscopic Devices Market – Impact of Coronavirus (COVID-19) Pandemic
The COVID-19 pandemic and consequent lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.
The COVID-19 pandemic also had a negative impact on the global laparoscopic devices market, due to potential risks in laparoscopy in COVID-19 patients. For instance, in March 2021, according to the data published in SAGE journal, laparoscopy is an aerosol forming procedure. During laparoscopic surgery, an artificial pneumoperitoneum is created in which aerosols are produced, which can spread to health care workers during the surgery. Therefore, it poses a potential risk for viral transmission of COVID-19 to healthcare workers.
Global Laparoscopic Devices Market: Key Developments
In March 2021, the U.S. Food and Drug Administration announced that they had authorized the Hominis Surgical System, the first and new robotically-assisted surgical device (RASD) that can help to facilitate transvaginal hysterectomy and salpingo-oophorectomy, manufactured by Memic Innovative Surgery, a medical device company. This robotically-assisted surgical device enables a surgeon to use computer and software technology to control and move surgical instruments through one or more tiny ports (incisions or orifices) in the patient’s body. The Hominis Surgical System uses minimally-invasive surgical instruments which are inserted through the vagina (transvaginal approach) and a video camera inserted laparoscopically through a small incision on the abdomen for visualization of the instruments inside the patient’s body.
Browse 36 Market Data Tables and 38 Figures spread through 175 Pages and in-depth TOC on “Global Laparoscopic Devices Market”- Forecast to 2030, Global Laparoscopic Devices Market, by Product Type (Direct Energy System Devices, Trocars/Access Devices, Internal Closure Devices, Laparoscopes, Hand Access Instruments, Insufflation Devices, Robotic Assisted Surgical System), by Therapeutic Application (Bariatric Surgery, Colorectal Surgery, General Surgery, Gynecological Surgery, Urological Surgery, Others (Hematology, etc.)), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/laparoscopic-devices-market-580
Key Takeaways of the Global Laparoscopic Devices Market:
- The global laparoscopic devices market is expected to exhibit a CAGR of 6.1% during the forecast period, due to the increasing adoption of inorganic strategies such as product approval by the regulatory authorities such as the U.S. Food and Drug Administration. For instance, in March 2020, TransEnterix, Inc., a medical device company announced that they had received 510(k) clearance for the Intelligent Surgical Unit (ISU) from the U.S. Food and Drug Administration. The Intelligent Surgical Unit (ISU) enables machine vision capabilities on the Senhance Surgical System and it’s hardware is designed in such a way that it will be compatible with surgical image analytics that are expected to continue to drive meaningful innovations in digital laparoscopy
- Among product type, the direct energy system devices segment are expected to hold a dominant position in the global laparoscopic devices market over the forecast period owing to the increasing adoption of inorganic strategies such as product launches by key market players. For instance, in September 2021, Olympus Corporation, a manufacturer of optics and reprography products, announced that they had launched POWERSEAL, an advanced bipolar surgical energy system device. The POWERSEAL device enables the surgeons with consistent sealing, dissection, and grasping capabilities in laparoscopic surgeries. The POWERSEAL device can be used in colorectal, bariatric, urological, gynecological, thoracic and vascular surgical procedures.
- Among regions, North America is expected to account for the largest market share in the global laparoscopic devices market over the forecast period, owing to the increasing number of bariatric procedures performed per year in the region. According to the data published in American Society for Metabolic and Bariatric Surgery, in June 2022, in the U.S. more than 122,056 bariatric surgery operations were performed in 2020.
- Major players operating in the global laparoscopic devices market include Olympus Corporation, B. Braun Melsungen AG, Intuitive Surgical Inc., Medtronic plc., Stryker Corporation, Smith & Nephew Plc., CareFusion Corporation, Johnson & Johnson (Ethicon), KARL STORZ GmbH & Co. KG, Richard Wolf GmbH, Endocontrol SA, Gordian Surgical Ltd., 270Surgical, and Tekno-Medical Optik Surgery GmbH.
